Search Results
May 13, 2026, 21:35 ET MAYFAIR GOLD REPORTS Q1 2026 OPERATING AND FINANCIAL RESULTS
gold company focused on advancing the 100% controlled Fenn-Gib Project in the Timmins region of Northern Ontario. The 2026 Pre-Feasibility Study (the "PFS") outlines the potential to develop Fenn-Gib into a new Canadian gold producer, with initial development capital of C$450 million, a base-case payback
More news about: Mayfair Gold Corp.
May 13, 2026, 11:19 ET The 5 Strategic Projects Quietly Defining the Next Decade of West's Critical Minerals Supply
ground on the Elk Creek mine portal in March. B2Gold's Goose Mine in Nunavut hit commercial production in October. Ivanhoe Electric's Santa Cruz copper PFS lands first cathode in 2028. The Western mega-asset list is short — and getting shorter.KEY TAKEAWAYS The list
More news about: American News Group
May 13, 2026, 08:45 ET Permitted, Funded, and Drilling: A Tanzanian Gold Developer Crosses the Pre-Construction Threshold
independent of the Company.Cautionary Note on Production Decision:Although Imwelo has been the subject of JORC-compliant PEA, PFS and updated PFS work, these foreign-code studies are not current under NI 43-101. The Company has not completed a feasibility study on Imwelo that establishes
More news about: Equity Insider
May 13, 2026, 04:00 ET MAYFAIR GOLD ADDS VP EXPLORATION AND TECHNICAL LEADERSHIP DEPTH
gold company focused on advancing the 100% controlled Fenn-Gib Project in the Timmins region of Northern Ontario. The 2026 Pre-Feasibility Study (the "PFS") outlines the potential to develop Fenn-Gib into a new Canadian gold producer, with initial development capital of C$450 million, a base-case payback
More news about: Mayfair Gold Corp.
May 12, 2026, 20:16 ET Denison Reports Financial and Operational Results for Q1 2026, Highlighted by Commencement of Site Preparation and Early Works for the Phoenix ISR Uranium Mine, and the Results of its Shareholder Meeting
Saskatchewan. In mid-2023, the Phoenix FS was completed for the Phoenix ISR mining operation, and an update to the 2018 Pre-Feasibility Study ("2018 PFS") was completed for the Gryphon deposit as a conventional underground mining operation (the "Gryphon Update"). Based on the respective studies, both deposits
More news about: Denison Mines Corp.
May 12, 2026, 07:00 ET Defense Metals Commences Pilot Flotation Test Program at SGS Lakefield for the Wicheeda Rare Earth Project
reserve, as detailed in the Company's 2025 Pre Feasibility Study ("PFS"; refer to Company News Release April 7th, 2025) prepared in accordance with National Instrument 43-101 Standards of Disclosure for Mineral Projects. The PFS shows the economic potential of the deposit and supports future
More news about: Defense Metals Corp.
May 12, 2026, 07:00 ET Rigel Enters Exclusive Global Licensing Agreement for VEPPANU™ (vepdegestrant), an oral PROTAC, for the Treatment of 2L+ ER+/HER2-, ESR1m Advanced or Metastatic Breast Cancer
demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS), reducing the risk of disease progression or death by 43% compared to fulvestrant. Median PFS was 5.0 months (95% CI: 3.7, 7.4) in the vepdegestrant arm and 2.1 months (95% CI: 1.9, 3.5) in the fulvestrant
More news about: Rigel Pharmaceuticals, Inc.
May 08, 2026, 08:30 ET Day One and Servier Complete Enrollment in Pivotal Phase 3 FIREFLY-2 Trial of Tovorafenib as a Front-Line Treatment for Pediatric Low-Grade Glioma (pLGG)
Response Assessment in Pediatric Neuro-Oncology Low-Grade Glioma (RAPNO-LGG) criteria, with key secondary endpoints including progression-free survival (PFS) and event-free survival (EFS) per RAPNO-LGG, time to next treatment (TTNT), overall survival (OS) and other measures, including patient-reported outcomes.
More news about: Servier Pharmaceuticals
May 08, 2026, 06:40 ET The sNDA for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First‑Line Treatment for PD-L1-positive NSCLC Accepted for Review by NMPA
PD-L1-positive locally advanced or metastatic NSCLC. At a pre-specified interim analysis, the study has met its primary endpoint of progression-free survival (PFS) and demonstrated a statistically significant and clinically meaningful improvement as concluded by the Independent Data Monitoring Committee (IDMC).
More news about: Kelun-Biotech
May 07, 2026, 11:00 ET Lake Victoria Gold Mobilizes Rigs for Sterilization Drilling at Imwelo as Project Advances Toward Production
independent of the Company.Cautionary Note on Production Decision:Although Imwelo has been the subject of JORC-compliant PEA, PFS and updated PFS work, these foreign-code studies are not current under NI 43-101. The Company has not completed a feasibility study on Imwelo that establishes
More news about: USA News Group
May 07, 2026, 09:00 ET Before the Drill Rigs Arrive at America's Largest Conventional Uranium Deposit, the Permitting Work Is Already Moving -- and Eagle Nuclear Just Made That Operationally Public
Operations, Vishal Gupta: "Initiating environmental baseline studies marks an important milestone in the responsible advancement of Aurora toward a PFS. These studies are designed to collect critical environmental data across multiple disciplines… Once collected, this data will support environmental
More news about: USA News Group
May 07, 2026, 07:00 ET Grounded Lithium Provides Oil & Gas Operations Update, Announces Annual General and Special Meeting and Option Grant
assumptions and expectations will prove to be correct. Such statements include, but are not limited to, statements pertaining to timing of filing a PFS, GLC's vision of becoming a best-in-class, environmentally responsible, Canadian lithium producer supporting the global energy transition, GLC's resource
More news about: Grounded Lithium Corp.
May 06, 2026, 09:00 ET A Positive Gold-Antimony PEA Just Landed in a Fast-Track Jurisdiction, with 19,000 Metres of Drilling Already Underway
Fast-Track Approvals permitting process, with the PFS targeted for Q4 2026.4. 19,000 metres turning right now. The infill and step-out drill program is underway, targeting both the conversion of Inferred Resources to Indicated ahead of PFS, and step-out drilling that has the potential to
More news about: Equity Insider
May 06, 2026, 07:00 ET Defense Metals Announces Commencement of the Spring 2026 Drill Program at Wicheeda Rare Earths Project
reserve, as detailed in the Company's 2025 Pre Feasibility Study ("PFS"; refer to Company News Release April 7th, 2025) prepared in accordance with National Instrument 43-101 Standards of Disclosure for Mineral Projects. The PFS shows the economic potential of the deposit and supports future
More news about: Defense Metals Corp.
May 05, 2026, 06:00 ET IDEAYA Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update
(Hazard Ratio of 0.42; 95% CI: 0.30, 0.59; p-value: <0.0001) and achieving a statistically significant improvement in median progression-free survival (PFS) of 6.9 months versus 3.1 months in the investigator choice of therapy (ICT) arm as assessed by blinded independent central review (BICR).On
More news about: IDEAYA Biosciences, Inc.
May 04, 2026, 04:30 ET Mayfair Gold Appoints Drew Anwyll, P.Eng., as CEO
mining jurisdiction. Most recently, Mr. Anwyll served as Mayfair's Chief Operating Officer, where he spearheaded the 2026 Pre-Feasibility Study (the "PFS") and the commencement of Front-End Engineering and Design (FEED) for the Fenn-Gib Project.Expertise in Provincial Permitting and Regulatory
More news about: Mayfair Gold Corp.
May 01, 2026, 04:05 ET ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to: the timing of the PFS events and topline data release for LOTIS-5 and the results of the trial, the timing for the sBLA submission, acceptance and outcome of review of the
More news about: ADC Therapeutics SA
Apr 30, 2026, 07:00 ET Hot Chili Quarterly Report - Period Ending 31 March 2026
and exclusions. The PFS Technical Report is intended to be read as a whole, and sections should not be read or relied upon out of context. The technical information in this report is subject to the assumptions and qualifications to be contained in the PFS Technical Report. The PFS Technical Report replaces
More news about: Hot Chili Limited
Apr 30, 2026, 06:00 ET IDEAYA Biosciences to Initiate New Drug Application Submission from the Darovasertib OptimUM-02 Trial under the Oncology Center of Excellence Real-time Oncology Review (RTOR) Program
(Hazard Ratio of 0.42; 95% CI: 0.30, 0.59; p-value: <0.0001) and achieving a statistically significant improvement in median progression-free survival (PFS) of 6.9 months versus 3.1 months in the investigator choice of therapy (ICT) arm as assessed by blinded independent central review (BICR). On secondary
More news about: IDEAYA Biosciences, Inc.
Apr 29, 2026, 16:05 ET INTEGRA RECEIVES FINAL APPROVAL OF EXPLORATION PLAN OF OPERATIONS FOR THE WILDCAT DEPOSIT, ADVANCING NEVADA NORTH PROJECT TOWARD PRE-FEASIBILITY STUDY
limited exploration authorizations.Advancing Toward PFS and Advanced Permitting: Work is underway to advance Nevada North from the 2023 Preliminary Economic Assessment ("PEA") stage toward a Pre-Feasibility Study ("PFS"), targeted for completion in H2 2027.Strategic Location:
More news about: Integra Resources Corp.
Apr 27, 2026, 18:35 ET Mayfair Gold Provides Update on Project Work in the First Quarter of 2026 Advancing and Derisking the Fenn-Gib Gold Project
designs within the area drilled. Upon completion, the updated local model will be compared against the MRE used in the Pre‑Feasibility Study (PFS) to assess changes in grade distribution, geological continuity, and provide insight into any variability on future mine planning and operational predictability.Ongoing
More news about: Mayfair Gold Corp.
Apr 27, 2026, 07:45 ET Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental Biologics License Application for Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Metastatic GEA
chemotherapy and tislelizumab; zanidatamab in combination with chemotherapy; and trastuzumab plus chemotherapy. The trial is evaluating dual primary endpoints, PFS per blinded independent central review (BICR) and OS. Results from the trial were
More news about: Jazz Pharmaceuticals plc
Apr 27, 2026, 07:30 ET ADC Therapeutics to Host First Quarter 2026 Financial Results Conference Call on May 4, 2026
actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to: the timing of the PFS events and topline data release for LOTIS-5 and the results of the trial, the timing for the sBLA submission, acceptance and outcome of review of the
More news about: ADC Therapeutics SA
Apr 23, 2026, 09:20 ET Smart Money Is Quietly Flooding Africa's Highest-Grade Gold Belt
supporting the Douta Gold Project Pre-Feasibility Study in Senegal, with no material differences from the PFS results previously reported at the beginning of the year in January.The Douta PFS outlines a pre-tax NPV5% of US$908 million and a pre-tax IRR of 73%, based on a gold price of US$3,500 per
More news about: Equity Insider
Apr 23, 2026, 03:00 ET MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia
total of 654 adults (age ≥18 years).The primary endpoint of the study is progression-free survival (PFS) by investigator assessment in the FL population, and the key secondary endpoints are PFS in the overall population as well as positron emission tomography complete response (PET-CR) and overall
More news about: Specialised Therapeutics